The New York Times, May 20, 2020

Link

Scientists are developing  more than 100coronavirus vaccines using a range of techniques, some of which are well-established and some of which have never been approved for medical use before.

Most of these vaccines target the so-called spike proteins that cover the virus and help it invade human cells. The immune system can develop antibodies that latch onto spike proteins and stop the virus.

A successful vaccine for the SARS-CoV-2 coronavirus would teach people’s immune systems to make antibodies against the virus without causing disease.

Continue reading “Different Approaches to a Coronavirus Vaccine”

The New York Times, May 20, 2020 (with Knvul Sheikh and Noah Weiland)

Link

In a medical research project nearly unrivaled in its ambition and scope, volunteers worldwide are rolling up their sleeves to receive experimental vaccines against the coronavirus — only months after the virus was identified.

Companies like Inovio and Pfizer have begun early tests of candidates in people to determine whether their vaccines are safe. Researchers at the University of Oxford in England are testing vaccines in human subjects, too, and say they could have one ready for emergency use as soon as September.

Moderna on Monday announced encouraging results of a safety trial of its vaccine in eight volunteers. There were no published data, but the news alone kindled hopes and sent the company’s stock soaring.

Continue reading “A New Entry in the Race for a Coronavirus Vaccine: Hope”

The New York Times, May 20, 2020

Link

A prototype vaccine has protected monkeys from the coronavirus, researchers reported on Wednesday, a finding that offers new hope for effective human vaccines.

Scientists are already testing coronavirus vaccines in people, but the initial trials are designed to determine safety, not how well a vaccine works. The research published Wednesday offers insight into what a vaccine must do to be effective and how to measure that.

“To me, this is convincing that a vaccine is possible,” said Dr. Nelson Michael, the director of the Center for Infectious Diseases Research at Walter Reed Army Institute of Research.

Continue reading “Prototype Vaccine Protects Monkeys From Coronavirus”

The New York Times, May 12, 2020

Link

TUSCALOOSA, Ala. — On a cold, gray winter day, Stephen Secor drove to the outskirts of town to catch up with some old friends. He pulled into the driveway of David and Amber Nelson, who welcomed him into their converted basement, filled with stacks of refrigerator-size, glass-doored cages. Each cage contained a massive snake. Some of the Nelsons’ pythons and boa constrictors were recent adoptions from Dr. Secor’s lab, a few miles to the west at the University of Alabama.

Dr. Secor and Mr. Nelson, a product manager at a local car parts factory, hoisted the snakes one at a time out of their cages.

Continue reading “Eat Rat, Make New Body: Easy Stuff for Pythons”

The New York Times, May 6, 2020

Link

All viruses mutate, and the coronavirus is no exception. But there is no compelling evidence yet that it is evolving in a way that has made it more contagious or more deadly.

A preprint study — posted online, but not published in a scientific journal and not yet peer-reviewed — has set the internet afire by suggesting otherwise.

On April 30, a report by a team led by Bette Korber, a biologist at Los Alamos National Laboratory in New Mexico, claimed to have found a mutation in the coronavirus that arose in Europe in February and then rapidly spread, becoming dominant as the virus was introduced into new countries.

Continue reading “Did a Mutation Turbocharge the Coronavirus? Not Likely, Scientists Say”